IWP Capital to Vote "FOR" FedEx Proposal 6 on Abortion-Drug Distribution Risk
Get Alerts FDX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.6%
EPS Growth %: -13.6%
Join SI Premium – FREE
Co-filer urges a board-level risk report as Comstock Act enforcement remains unsettled ahead of the
The proposal is precatory and procedural. It asks FedEx's board to report, within one year and at reasonable cost, on how it oversees the legal, regulatory, and reputational risks of transporting mail-order abortion drugs such as mifepristone. It does not ask FedEx to stop shipping any lawful product or to inspect packages.
"We are asking a board that emphasizes risk oversight to tell its owners how it is preparing for a criminal statute whose enforcement is genuinely unsettled," said
IWP notes the reputational pressure runs both ways — from investors urging continued access and from faith-based coalitions — giving the board a governance reason to document its reasoning. IWP Capital intends to vote FOR Proposal 6 and encourages fellow shareholders to review the proposal and consider doing the same.
IMPORTANT NOTICE
This press release is a public statement by IWP Capital, LLC, a shareholder of FedEx Corporation, of how it intends to vote on Proposal 6 and its reasons for that decision. It is furnished in reliance on Rule 14a-1(l)(2)(iv) under the Securities Exchange Act of 1934 and is not a solicitation of authority to vote any proxy. IWP Capital is NOT asking for, and will NOT accept, proxy cards; any proxy card received will be returned. IWP Capital cannot vote your shares and is not requesting the authority to do so. Shareholders should vote using only the official proxy materials distributed by FedEx.
View original content:https://www.prnewswire.com/news-releases/iwp-capital-to-vote-for-fedex-proposal-6-on-abortion-drug-distribution-risk-302882388.html
SOURCE IWP Capital, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
- Dorsata, Inc. Notifies Patients of Metabase Data Security Incident
- Denver Arts Week Returns Nov. 6-15
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share